Supply of the medicinal product lanreotide in 2027

Summary

The Masaryk Memorial Cancer Institute is procuring supplies of the medicinal product lanreotide under one lot for use during 2027. The contract covers the requested package sizes and strengths; the buyer may order up to 50% more or less than the indicative quantity. The contract period may be extended once by three months if a replacement supply contract is not in place.